Cargando…
TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients
Loss of pancreatic β–cell is a critical factor in the pathogenesis of type 1 diabetes and it also occurs in type 2. TXNIP (thioredoxin – interacting protein), also known as vitamin D3-upregulated protein 1, or thioredoxin-binding-protein-2, regulates this process and modulates cellular redox balance...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387585/ https://www.ncbi.nlm.nih.gov/pubmed/36060506 http://dx.doi.org/10.15386/mpr-2187 |